Four-Year Outcome of Aflibercept Treatment-Naïve Patients for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting

INTRODUCTION: The objective of the study is to report 4-year treatment outcome with intravitreal Aflibercept injections for neovascular age-related macular degeneration (nAMD) as first life therapy in real-life. Patients and Methods. This is a prospective, monocenter, observational case series analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Gayadine-Harricham, Yanel, Rufin, Virginie, Law-Koune, Sandrine, Tran, Thi Ha Chau
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155756/
https://www.ncbi.nlm.nih.gov/pubmed/32318284
http://dx.doi.org/10.1155/2020/7465270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155756/
https://www.ncbi.nlm.nih.gov/pubmed/32318284
http://dx.doi.org/10.1155/2020/7465270

Ejemplares similares